NCT06294054View on ClinicalTrials.gov

Bladder Cancer and Neoadjuvant Chemotherapy Efficiency Before Cystectomy

Active, not recruitingOBSERVATIONAL
Enrollment

707

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Bladder CancerGenomic Instability
Interventions
COMBINATION_PRODUCT

neoadjuvant chemotherapy with cisplatine

Blood from patient having muscle invasive bladder cancer who benefit from neoadjuvant chemotherapy with cisplatine

Trial Locations (7)

Unknown

Centre de lutte contre le cancer François Baclesse, Caen

Centre de recherche des Cordeliers, Paris

Hôpital Saint-Louis AP-HP, Paris

Institut Curie Centre de Recherche, Paris

Institut Curie, Paris

Institut Gustave Roussy, Paris

Mines ParisTech, Paris

All Listed Sponsors
collaborator

Institut Curie

OTHER

lead

University Hospital, Rouen

OTHER